Unmasking Pharma Impurities: Navigating Challenges with USP Perspective
Webinar
As the regulatory landscape evolves, managing nitrosamines and complex impurity profiles remains a top priority for global drug safety. Our guest speakers will unpack the practical realities of modern impurity management and discuss the evolving global frameworks keeping patient safety secure:
- Mastering Risk Assessment: Strategic frameworks for identifying and evaluating nitrosamine and critical impurity risks in manufacturing.
- Navigating Regulatory Guidance: The role of pharmacopoeias as part of the regulatory framework on nitrosamines.
- The Reference Material Challenge: Practical solutions for sourcing and developing high-precision reference standards for newly identified and complex impurities.
Speakers

Dr. Christian Zeine
The United States Pharmacopeia (USP)
Senior Manager Scientific Affairs, EMEA
Christian is Senior Manager in the Scientific Affairs Group for the EMEA region, with a focus on Small Molecules, USP’s General Chapters and Biologics. He collaborates with scientific experts and stakeholders and is responsible to protect and grow USP’s scientific reputation in the region and globally. Before joining USP, Christian worked for seventeen years in the field of pharmaceutical reference standards with a focus on impurities, and before that in the IVD (In Vitro Diagnostic) industry. His scientific expertise includes impurity testing, reference standards characterization and adjacent fields. Christian has published several articles and white papers on topics such as impurities, overview about (certified) reference materials, and the use of reference standards in method development and validation.

Dr. Ulrich Reichert, M.D.R.A.
Merck Life Science KGaA, Darmstadt, Germany
Head of CDMO and Bioprocess Materials
Ulrich leads a global team supporting regulatory compliance for manufacturing active and biologic drug substances, including site registrations worldwide. With over 25 years of experience in regulatory and quality roles, he holds a PhD in Medicinal Chemistry and a Master in Drug Regulatory Affairs. Ulrich chairs the IPEC Europe Nitrosamine Task Force, participates in ICH and European Pharmacopoeia expert groups, and serves on the pharmacopoeia committee on medicinal chemistry at BfArM.
Analytical chemistry
- Analytical chemistry
Duration:1h
Language:English
Session 1:Thu, October 15, 2026 3:00 PM CEST